Results 171 to 180 of about 96,415 (362)
GBD 2015: migraine is the third cause of disability in under 50s [PDF]
Steiner, TJ, Stovner, LJ, Vos, T
core +1 more source
Parental and comorbid migraine in individuals with bipolar disorder: A nationwide register study [PDF]
Dan Sucksdorff +5 more
openalex +1 more source
Interstitial Cystitis/Bladder Pain Syndrome in Men
ABSTRACT Aims In April 2025, the Wake Forest Institute for Regenerative Medicine hosted a Global Consensus meeting on interstitial cystitis/bladder pain syndrome (IC/BPS) in Winston‐Salem, NC. The goal of this meeting was to establish attainable targets in phenotyping, diagnosis, and biomarkers for IC/BPS.
Madeline Snipes +5 more
wiley +1 more source
ABSTRACT Aims The objective of this study was to assess the duration and clinical correlates of positive response in interstitial cystitis/bladder pain syndrome patients undergoing therapeutic bladder hydrodistension (HOD) or HOD with electrofulguration (for those with Hunner lesions).
Dylan T. Wolff +5 more
wiley +1 more source
ABSTRACT The presence of excess weight is no longer a distinguishing feature between patients with type 1 diabetes (T1D) and those with type 2 diabetes (T2D). Obesity treatment in patients with T2D improves glycemic control and reduces or even eliminates medication burden.
Kathleen R. Ruddiman +2 more
wiley +1 more source
ABSTRACT Background Methotrexate‐associated leukoencephalopathy is poorly documented in osteosarcoma. Since 2007, our institution has monitored osteosarcoma patients with sequential magnetic resonance imaging (MRI) and neuropsychological evaluations during treatment and follow‐up.
Sandra Raimbault +13 more
wiley +1 more source
Correction: Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders [PDF]
Gülşen Kocaman +7 more
openalex +1 more source
Migraine with Brainstem Aura Accompanied by Disorders of Consciousness
Sui-yi Xu +4 more
openalex +2 more sources
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel +5 more
wiley +1 more source

